BACKGROUND: It is believed that some cases of aseptic failure of THA may be attributable to occult infections. However, it is unclear whether preoperative erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are more likely elevated in these patients than those without overt infection. QUESTIONS/PURPOSES: We asked whether some patients with aseptic THA failures have abnormal serologic indicators of periprosthetic joint infection (PJI) at the time of revision, namely ESR and/or CRP. METHODS: Three hundred twenty-three revision THAs for aseptic loosening from 2004 to 2007 were retrospectively evaluated. We categorized all cases into two groups: (1) those with overt PJI (n = 14) plus patients who had a positive intraoperative culture during the index revision (n = 13) and (2) those who did not require rerevision (n = 276) or required surgery for noninfected causes (n = 20). Mean and frequency of abnormal ESR and CRP were compared between the two groups. The minimum followup was 11 months (average, 35 months; range, 11-54 months). RESULTS: The mean and frequency of abnormal CRP in first group (n = 27) at 2.1 mg/dL and 48% respectively, were greater than those of the uninfected (n = 296) at 1.2 mg/dL and 27%, respectively. However, there were no differences between two groups regarding mean or frequency of abnormal ESR. CONCLUSION: Some patients with presumed aseptic loosening may have abnormal serologic indicators of PJI that either have escaped diagnosis or were not adequately investigated. All patients undergoing revision THA should have ESR and CRP measured preoperatively and those with abnormal CRP should have additional evaluations to rule out or confirm PJI.
BACKGROUND: It is believed that some cases of aseptic failure of THA may be attributable to occult infections. However, it is unclear whether preoperative erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are more likely elevated in these patients than those without overt infection. QUESTIONS/PURPOSES: We asked whether some patients with aseptic THA failures have abnormal serologic indicators of periprosthetic joint infection (PJI) at the time of revision, namely ESR and/or CRP. METHODS: Three hundred twenty-three revision THAs for aseptic loosening from 2004 to 2007 were retrospectively evaluated. We categorized all cases into two groups: (1) those with overt PJI (n = 14) plus patients who had a positive intraoperative culture during the index revision (n = 13) and (2) those who did not require rerevision (n = 276) or required surgery for noninfected causes (n = 20). Mean and frequency of abnormal ESR and CRP were compared between the two groups. The minimum followup was 11 months (average, 35 months; range, 11-54 months). RESULTS: The mean and frequency of abnormal CRP in first group (n = 27) at 2.1 mg/dL and 48% respectively, were greater than those of the uninfected (n = 296) at 1.2 mg/dL and 27%, respectively. However, there were no differences between two groups regarding mean or frequency of abnormal ESR. CONCLUSION: Some patients with presumed aseptic loosening may have abnormal serologic indicators of PJI that either have escaped diagnosis or were not adequately investigated. All patients undergoing revision THA should have ESR and CRP measured preoperatively and those with abnormal CRP should have additional evaluations to rule out or confirm PJI.
Authors: Nelson V Greidanus; Bassam A Masri; Donald S Garbuz; S Darrin Wilson; M Gavan McAlinden; Min Xu; Clive P Duncan Journal: J Bone Joint Surg Am Date: 2007-07 Impact factor: 5.284
Authors: Carl L Nelson; Alex C McLaren; Sandra G McLaren; Jeffrey W Johnson; Mark S Smeltzer Journal: Clin Orthop Relat Res Date: 2005-08 Impact factor: 4.176
Authors: M M Tunney; S Patrick; M D Curran; G Ramage; D Hanna; J R Nixon; S P Gorman; R I Davis; N Anderson Journal: J Clin Microbiol Date: 1999-10 Impact factor: 5.948
Authors: Elie F Berbari; Camelia Marculescu; Irene Sia; Brian D Lahr; Arlen D Hanssen; James M Steckelberg; Rachel Gullerud; Douglas R Osmon Journal: Clin Infect Dis Date: 2007-09-26 Impact factor: 9.079
Authors: Larry L Nguyen; Carl L Nelson; Michael Saccente; Mark S Smeltzer; David L Wassell; Sandra G McLaren Journal: Clin Orthop Relat Res Date: 2002-10 Impact factor: 4.176
Authors: David G Partridge; Reena Rambani; Robert M Kerry; Ian Stockley; Robert Townsend Journal: Clin Orthop Relat Res Date: 2011-10 Impact factor: 4.176
Authors: Ashkan Rashad; Stefan Schwan; Alireza Nasirpour; Inge Schmitz; Henning Hanken; Reinhard E Friedrich; Martin Gosau Journal: In Vivo Date: 2021 May-Jun Impact factor: 2.155
Authors: Vinay K Aggarwal; Carlos Higuera; Gregory Deirmengian; Javad Parvizi; Matthew S Austin Journal: Clin Orthop Relat Res Date: 2013-10 Impact factor: 4.176
Authors: Anthony T Tokarski; Joseph O'Neil; Carl A Deirmengian; Joseph Ferguson; Gregory K Deirmengian Journal: Clin Orthop Relat Res Date: 2013-10 Impact factor: 4.176
Authors: Erik Schiffner; David Latz; Simon Thelen; Jan P Grassmann; Alfred Karbowski; Joachim Windolf; Johannes Schneppendahl; Pascal Jungbluth Journal: J Clin Orthop Trauma Date: 2018-09-26
Authors: E Schiffner; D Latz; A Karbowski; J P Grassmann; S Thelen; J Windolf; P Jungbluth; J Schneppendahl Journal: J Clin Orthop Trauma Date: 2019-05-07